← Back to Search

Behavioural Intervention

High Intensity Interval Training for Congenital Heart Disease

N/A
Recruiting
Led By Michael Khoury, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children and adolescents aged 10-18 years
Repaired moderate-complex congenital heart disease
Must not have
New York Heart Association class II or worse symptoms
Cognitive impairment limiting the communication needed for the HIIT program
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of a home-based high intensity interval training program on exercise capacity in adolescents with repaired congenital heart disease.

Who is the study for?
This trial is for children and teens aged 10-18 with repaired moderate-complex congenital heart disease. They must speak English, have space at home for the MedBIKE system, and not be restricted from exercising by their cardiologist. Those with severe symptoms, cognitive impairments affecting communication, or recent serious arrhythmias cannot participate.
What is being tested?
The study tests a home-based high-intensity interval training (HIIT) program using a telemedicine-equipped video game-linked cycle ergometer called MedBIKE™. It aims to improve exercise capacity in youth with congenital heart disease through this novel cardiac rehabilitation approach.
What are the potential side effects?
While specific side effects are not listed, HIIT programs can generally cause increased heart rate during exercise, fatigue afterwards, muscle soreness and may pose risks if there's an underlying health condition that hasn't been adequately assessed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 10 and 18 years old.
Select...
I had surgery to fix a moderate to complex heart defect.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My heart condition limits my physical activity.
Select...
I have difficulty communicating which may affect my participation in the HIIT program.
Select...
I have a heart or birth defect that limits my ability to exercise.
Select...
I have experienced chest pain when I exert myself.
Select...
I have not had serious heart rhythm problems in the last year.
Select...
My oxygen levels are often below 85% without support.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Exercise capacity in the change in VO2peak (mL/kg/min) measured through CPET testing
Secondary study objectives
Changes in Health-Related Quality of Life as measured using the TNO AZL Children's Quality of Life (TACQOL) questionnaire.
Changes in endothelial function to determine arterial volume will be measured using an EndoPAT 2000 instrument.
Changes in physical activity, defined as time spent in moderate to vigorous physical activity (MVPA) and sedentary time, measured by wearing an accelerometer for 7-days prior and 7-days post MedBIKE intervention
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MedBIKE HIITExperimental Treatment1 Intervention
MedBIKE HIIT Exercise Program

Find a Location

Who is running the clinical trial?

Heart and Stroke Foundation of CanadaOTHER
130 Previous Clinical Trials
72,747 Total Patients Enrolled
University of AlbertaLead Sponsor
940 Previous Clinical Trials
433,999 Total Patients Enrolled
Michael Khoury, MDPrincipal InvestigatorUniversity of Alberta
2 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

MedBIKE HIIT (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04575883 — N/A
Congenital Heart Disease Research Study Groups: MedBIKE HIIT
Congenital Heart Disease Clinical Trial 2023: MedBIKE HIIT Highlights & Side Effects. Trial Name: NCT04575883 — N/A
MedBIKE HIIT (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04575883 — N/A
~15 spots leftby Dec 2025